Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of intravitreal ocriplasmin prior to pars plana vitrectomy
2010-018919-16Phase 2Completed
- Sponsor
- Oxurion
- Start
- May 2010
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ocriplasmin in Vitreous disorder, sponsored by Oxurion. Primary endpoints: Safety endpoints and Pharmacokinetic endpoints. Started May 2010; status: completed.
02
Drugs
ocriplasmin
03
Conditions
Vitreous disorder
Beyond the preview
Go deeper on 2010-018919-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018919-16.